In an elderly patient with established normal‑pressure hydrocephalus who develops secondary bacterial meningitis, should an external ventricular drain be placed as a temporizing measure?

Yes, external ventricular drainage (EVD) should be strongly considered in NPH patients who develop secondary bacterial meningitis with hydrocephalus.

In patients with normal-pressure hydrocephalus complicated by bacterial meningitis, placement of an external ventricular drain is indicated when obstructive hydrocephalus develops, as it serves as both a life-saving temporizing measure and facilitates infection clearance through CSF drainage. 1

Clinical Decision Framework

When EVD is Indicated

The 2016 ESCMID guidelines explicitly state that in most patients with obstructive hydrocephalus complicating bacterial meningitis, placement of an external ventricular drain is indicated 1. This applies directly to your NPH patient who develops secondary bacterial meningitis with worsening hydrocephalus.

Key indicators for EVD placement include:

• Obstructive hydrocephalus on imaging (CT or MRI)
• Neurologic deterioration (decreased consciousness, focal deficits)
• Elevated intracranial pressure requiring urgent decompression
• Need for CSF drainage to clear infection and prevent herniation 1

Evidence Supporting EVD Use

The rationale is multifold:

1. Infection clearance: EVD allows continuous drainage of infected CSF, which accelerates ventriculitis resolution. The 2004 guidelines note that "the ventriculitis of the shunt infection appears to clear more rapidly with the drainage catheter" 2

2. Pressure management: Recent case evidence demonstrates that EVD can rapidly reduce intracranial pressure (from 20 to 10 cmH₂O within 2 days) in bacterial meningitis with hydrocephalus 3

3. Temporizing measure: EVD allows continued hydrocephalus treatment while the infection is being controlled with antimicrobials, before definitive shunt placement 4

4. Improved outcomes: A 2025 case report emphasizes that "prompt implementation of EVD can play a pivotal role in improving patient outcomes" in pyogenic ventriculitis with hydrocephalus 5

Critical Management Considerations

Timing and Duration

• Act promptly when imaging shows progressive ventricular enlargement or intraventricular pus accumulation 5
• Maintain EVD until imaging confirms complete resolution of intraventricular infection—this may require 15+ days of drainage 5
• Do not rush to remove the drain; one case required a second EVD after premature removal led to status epilepticus 5

Infection Risk vs. Benefit

While EVD carries infection risk (13.3% in one series with long-tunneled EVD up to 44 days) 6, this must be weighed against:

• The 50% mortality rate associated with hydrocephalus complicating bacterial meningitis 7
• Hydrocephalus being an independent predictor of death (OR 7.81) in bacterial meningitis 7

The mortality risk from untreated hydrocephalus far exceeds the infection risk from EVD placement.

Special Consideration for Communicating Hydrocephalus

The guidelines make an important distinction: In patients with communicating hydrocephalus who are awake and can be monitored clinically, invasive measures might not be necessary 1. However, given that:

• NPH is typically a communicating hydrocephalus
• Bacterial meningitis can convert this to obstructive hydrocephalus through inflammatory adhesions
• Your patient has secondary bacterial meningitis complicating existing NPH

You must assess whether the hydrocephalus has become obstructive or if there is clinical deterioration warranting intervention.

Common Pitfalls to Avoid

1. Delaying intervention: Waiting for "medical management to work" when imaging shows progressive ventricular enlargement can be fatal 5, 7

2. Premature EVD removal: Remove only after imaging confirms resolution of intraventricular infection, not just clinical improvement 5

3. Assuming poor outcomes negate intervention: While outcomes are often poor (69% unfavorable in one series) 7, this reflects disease severity, not EVD futility—untreated cases fare worse

4. Overlooking imaging follow-up: Serial CT or MRI is crucial to monitor for progression requiring urgent EVD 5

Antimicrobial Considerations

Continue appropriate systemic antimicrobials per guidelines (typically 21 days for gram-negative bacilli, 10-14 days for pneumococcus) 2. Consider intraventricular antimicrobials through the EVD if the organism is resistant or response is inadequate (vancomycin 10-20mg daily, gentamicin 4-8mg daily for adults) 2.